Erratum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035))

  1. Rondeau, E.
  2. Scully, M.
  3. Ariceta, G.
  4. Barbour, T.
  5. Cataland, S.
  6. Heyne, N.
  7. Miyakawa, Y.
  8. Ortiz, S.
  9. Swenson, E.
  10. Vallee, M.
  11. Yoon, S.-S.
  12. Kavanagh, D.
  13. Haller, H.
  14. Babu, S.
  15. Broeders, N.
  16. Lietar, N.
  17. Brown, F.
  18. Campbell, P.
  19. Chowdhury, P.
  20. Kasimatis, T.
  21. Cirami, L.
  22. Caroti, L.
  23. Antognoli, G.
  24. Delmas, Y.
  25. Dobronravov, V.
  26. Gaeckler, A.
  27. Garrouste, C.
  28. Greenwood, G.
  29. Griffin, S.
  30. Huang, C.-C.
  31. Chen, I.-R.
  32. Huang, S.
  33. Kim, J.S.
  34. La Manna, G.
  35. Comai, G.
  36. Cappuccilli, M.
  37. Le Quintrec, M.
  38. Jeantet, G.
  39. Fumie, I.
  40. Luque, Y.
  41. Menne, J.
  42. Morelle, J.
  43. Goffin, E.
  44. Muhlfeld, A.
  45. Nagaraj, S.
  46. Arepally, G.
  47. Oh, D.
  48. Okumi, M.
  49. Terente, M.P.
  50. Gutierréz, E.
  51. Rodriguez, P.
  52. Provot, F.
  53. Schönermarck, U.
  54. Fischereder, M.
  55. Terrada, N.R.
  56. Seitz-Polski, B.
  57. Favre, G.
  58. Boyer-Suavet, S.
  59. Vinogradova, M.
  60. Kirsanova, T.
  61. Wong, E.K.S.
  62. Mostrar todos los/as autores/as +
Revista:
Kidney International

ISSN: 1523-1755,  0085-2538

Año de publicación: 2020

Volumen: 98

Número: 6

Páginas: 1621

Tipo: Errata

DOI: 10.1016/J.KINT.2020.11.001 GOOGLE SCHOLAR lock_openAcceso abierto editor
Fuente de los datos: Scopus